Form D · Pharmaceuticals
BriaCell Therapeutics Corp.
West Vancouver, A1 · CIK 0001610820
Offering snapshot reported Jun 15, 2021 · SEC filing
- Reported sold
- $27.2M Offering amount: $27.2M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 3, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2021 | Initial | $27,195,924 | No comparison | 12 | SEC filing |
| Apr 10, 2018 | Initial | $800,000 | No comparison | 3 | SEC filing |
| Dec 12, 2014 | Initial | $6,006,150 | No comparison | 7 | SEC filing |
| Jun 20, 2014 | Initial | $299,301 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $2.18M
- Finders' fees
- $0
- Form D file number
- 021-403035
Offering consists of 4,370,343 common shares at a purchase price of USD 5.26; 800,000 pre-funded warrants at a purchase price of USD 5.25 with an exercise price of USD 0.01 per share and 5,170,343 warrants with an exercise price of USD 6.19 per share
The above amount reflects a cash fee equal to 8% of gross proceeds, including exercise price of the pre-funded warrants. The Placement Agent also received a number of warrants equal to 5% of the Units sold in this offering.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| ThinkEquity, a division of Fordham Financial Management, Inc. | 20996 |
Source: Form D, filed Jun 15, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Saeid Babaei | Director |
| Saeid Babei | Director |
| Jamieson Bondarenko | Director, Executive |
| Vaughn Embro Pantalony | Director |
| Bev Funston | Director, Executive |
| Chris Healey | Director |
| Gadi Levin | Executive |
| Isaac Maresky | Director |
| Martin Schmieg | Director |
| Rahoul Sharan | Director |
| Rebecca Taub | Director |
| Jevin Werbes | Director, Executive |
| William Williams | Director, Executive |
| Charles Wiseman | Director |
| Matthew G. Wright | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Suite 300 235 15 Th Street
West Vancouver, A1, V7T2X1
West Vancouver, A1, V7T2X1